首页> 外文期刊>Molecular Microbiology >Single amino acid substitutions in either YhjD or MsbA confer viability to 3-deoxy-D-manno-oct-2-ulosonic acid-depleted Escherichia coli
【24h】

Single amino acid substitutions in either YhjD or MsbA confer viability to 3-deoxy-D-manno-oct-2-ulosonic acid-depleted Escherichia coli

机译:YhjD或MsbA中的单个氨基酸取代可赋予枯竭3-脱氧-D-甘露聚糖-辛-2-磺酸的大肠埃希菌

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The Escherichia coli K-12 strain KPM22, defective in synthesis of 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo), is viable with an outer membrane (OM) composed predominantly of lipid IVA, a precursor of lipopolysaccharide (LPS) biosynthesis that lacks any glycosylation. To sustain viability, the presence of a second-site suppressor was proposed for transport of lipid IVA from the inner membrane (IM), thus relieving toxic side-effects of lipid IVA accumulation and providing sufficient amounts of LPS precursors to support OM biogenesis. We now report the identification of an arginine to cysteine substitution at position 134 of the conserved IM protein YhjD in KPM22 that acts as a compensatory suppressor mutation of the lethal Delta Kdo phenotype. Further, the yhjD400 suppressor allele renders the LPS transporter MsbA dispensable for lipid IVA transmembrane trafficking. The independent derivation of a series of non-conditional KPM22-like mutants from the Kdo-dependent parent strain TCM15 revealed a second class of suppressor mutations localized to MsbA. Proline to serine substitutions at either residue 18 or 50 of MsbA relieved the Kdo growth dependence observed in the isogenic wild-type strain. The possible impact of these suppressor mutations on structure and function are discussed by means of a computationally derived threading model of MsbA.
机译:大肠杆菌K-12菌株KPM22,在合成3-脱氧-D-甘露聚糖-辛-2-氟糖酸(Kdo)时存在缺陷,可与主要由脂质IVA(脂多糖的前体)组成的外膜(OM)结合使用(LPS)缺乏任何糖基化的生物合成。为了维持生存力,有人建议使用第二位抑制剂来从内膜(IM)转运脂质IVA,从而减轻脂质IVA积累的毒性副作用,并提供足够量的LPS前体来支持OM生物发生。现在,我们报告在KPM22中保守IM蛋白YhjD的第134位上的半胱氨酸取代为半胱氨酸的鉴定,该蛋白充当致死性Delta Kdo表型的补偿性抑制突变。此外,yhjD400抑制剂等位基因使LPS转运蛋白MsbA可用于脂质IVA跨膜运输。从依赖Kdo的亲本菌株TCM15的一系列非条件KPM22样突变体的独立派生揭示了第二类抑制突变位于MsbA。在MsbA的第18或50位残基上脯氨酸被丝氨酸取代,可以缓解在同基因野生型菌株中观察到的Kdo生长依赖性。这些抑制基因突变对结构和功能的可能影响将通过MsbA的计算得出的线程模型进行讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号